negatives of glp 1 Long-Term Effects GLP-1 Medications: What You Should Know Can one drug do it

KDs are being intensely studied as options for the treatment of disorders that involve metabolic changes, including obesity, type 2 diabetes, cardiovascular disease, cancer and dementia (813)

Propionyl-L-carnitine shows particular promise for peripheral vascular disease and heart failure, with some trials demonstrating improved exercise tolerance.[8][9] LCAR supplementation improves glucolipid metabolism, reducing fasting glucose, insulin resistance, triglycerides, and liver enzymes.[10] Both compounds exhibit excellent safety profiles with minimal side-effects, though recent data raises concerns about substantial TMAO production (reaching 50 M plasma levels) from both supplements, which may have adverse cardiovascular implications.[1][8][3] References Potential Therapeutic Role of Carnitine and Acetylcarnitine in Neurological Disorders

The potential for long-acting GLP-1 receptor agonists could improve patient adherence and further optimize treatment outcomes

BPC-157 has no sequence overlap with other gut peptides and works in extremely tiny doses (micrograms to nanograms in animal studies)

& Voet, J

The most commonly studied combination is CJC-1295 with Ipamorelin, pairing a GHRH analog (CJC-1295, stimulates somatotroph GHRH receptors) with a growth hormone secretagogue (Ipamorelin, stimulates GHSR-1a receptors)